BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 33818053)

  • 1. Minority Enrollment to Clinical Trials: Road to Increased Access.
    Vose J
    Oncology (Williston Park); 2021 Mar; 35(3):107. PubMed ID: 33818053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial and Ethnic Disparities in Primary Open-Angle Glaucoma Clinical Trials: A Systematic Review and Meta-analysis.
    Allison K; Patel DG; Greene L
    JAMA Netw Open; 2021 May; 4(5):e218348. PubMed ID: 34003274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Participation in cancer clinical trials: race-, sex-, and age-based disparities.
    Murthy VH; Krumholz HM; Gross CP
    JAMA; 2004 Jun; 291(22):2720-6. PubMed ID: 15187053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial/Ethnic Disparities in Ophthalmology Clinical Trials Resulting in US Food and Drug Administration Drug Approvals From 2000 to 2020.
    Berkowitz ST; Groth SL; Gangaputra S; Patel S
    JAMA Ophthalmol; 2021 Jun; 139(6):629-637. PubMed ID: 33885724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparities in the Inclusion of Racial and Ethnic Minority Groups and Older Adults in Prostate Cancer Clinical Trials: A Meta-analysis.
    Riaz IB; Islam M; Ikram W; Naqvi SAA; Maqsood H; Saleem Y; Riaz A; Ravi P; Wang Z; Hussain SA; Warner JL; Odedina FT; Duma N; Singh P; Kehl KL; Kamran SC; Murad MH; Landman A; Van Allen E; Bryce AH
    JAMA Oncol; 2023 Feb; 9(2):180-187. PubMed ID: 36416812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enrollment of Older Patients, Women, and Racial/Ethnic Minority Groups in Contemporary Acute Coronary Syndrome Clinical Trials: A Systematic Review.
    Tahhan AS; Vaduganathan M; Greene SJ; Alrohaibani A; Raad M; Gafeer M; Mehran R; Fonarow GC; Douglas PS; Bhatt DL; Butler J
    JAMA Cardiol; 2020 Jun; 5(6):714-722. PubMed ID: 32211813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Under-representation of racial minorities in prostate cancer studies submitted to the US Food and Drug Administration to support potential marketing approval, 1993-2013.
    Wissing MD; Kluetz PG; Ning YM; Bull J; Merenda C; Murgo AJ; Pazdur R
    Cancer; 2014 Oct; 120(19):3025-32. PubMed ID: 24965506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enrollment of Individuals From Racial and Ethnic Minority Groups in Gynecologic Cancer Precision Oncology Trials.
    Mattei LH; Robb L; Banning K; Polan RM; Cote ML
    Obstet Gynecol; 2022 Oct; 140(4):654-661. PubMed ID: 36075065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enrollment of Older Patients, Women, and Racial and Ethnic Minority Individuals in Valvular Heart Disease Clinical Trials: A Systematic Review.
    Reddy KP; Faggioni M; Eberly LA; Halaby R; Sanghavi M; Lewey J; Mehran R; Coylewright M; Herrmann HC; Giri J; Fanaroff AC; Nathan AS
    JAMA Cardiol; 2023 Sep; 8(9):871-878. PubMed ID: 37494015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. U.S. racial and ethnic participation in global clinical trials by therapeutic areas.
    Lolic M; Araojo R; Okeke M; Temple R
    J Clin Pharm Ther; 2021 Dec; 46(6):1576-1581. PubMed ID: 34544200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Participation of Patients From Racial and Ethnic Minority Groups in Phase 1 Early Cancer Drug Development Trials in the US, 2000-2018.
    Dunlop H; Fitzpatrick E; Kurti K; Deeb S; Gillespie EF; Dover L; Yerramilli D; Gomez SL; Chino F; Tsai CJ
    JAMA Netw Open; 2022 Nov; 5(11):e2239884. PubMed ID: 36326764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial and ethnic underrepresentation in dermatology clinical trials.
    Mineroff J; Nguyen JK; Jagdeo J
    J Am Acad Dermatol; 2023 Aug; 89(2):293-300. PubMed ID: 37062462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do Current Lung Cancer Clinical Trials Represent All Patient Populations Including Minorities?
    Nemala A; Ullah A; Yacur M; Karim NA
    Clin Lung Cancer; 2023 Nov; 24(7):573-580. PubMed ID: 37574437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial and Ethnic Disparities Among Participants in Precision Oncology Clinical Studies.
    Aldrighetti CM; Niemierko A; Van Allen E; Willers H; Kamran SC
    JAMA Netw Open; 2021 Nov; 4(11):e2133205. PubMed ID: 34748007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Demographic Analysis of Racial/Ethnic Minority Enrollment Into HVTN Preventive Early Phase HIV Vaccine Clinical Trials Conducted in the United States, 2002-2016.
    Huamani KF; Metch B; Broder G; Andrasik M
    Public Health Rep; 2019; 134(1):72-80. PubMed ID: 30517057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responding to racial and ethnic disparities in use of HIV drugs: analysis of state policies.
    Morin SF; Sengupta S; Cozen M; Richards TA; Shriver MD; Palacio H; Kahn JG
    Public Health Rep; 2002; 117(3):263-72; discussion 231-2. PubMed ID: 12432137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation and Comparison of Current and Future Racial/Ethnic Representation in the US Health Care Workforce.
    Salsberg E; Richwine C; Westergaard S; Portela Martinez M; Oyeyemi T; Vichare A; Chen CP
    JAMA Netw Open; 2021 Mar; 4(3):e213789. PubMed ID: 33787910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partnering around cancer clinical trials (PACCT): study protocol for a randomized trial of a patient and physician communication intervention to increase minority accrual to prostate cancer clinical trials.
    Eggly S; Hamel LM; Heath E; Manning MA; Albrecht TL; Barton E; Wojda M; Foster T; Carducci M; Lansey D; Wang T; Abdallah R; Abrahamian N; Kim S; Senft N; Penner LA
    BMC Cancer; 2017 Dec; 17(1):807. PubMed ID: 29197371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten-Year Trends in Enrollment of Women and Minorities in Pivotal Trials Supporting Recent US Food and Drug Administration Approval of Novel Cardiometabolic Drugs.
    Khan MS; Shahid I; Siddiqi TJ; Khan SU; Warraich HJ; Greene SJ; Butler J; Michos ED
    J Am Heart Assoc; 2020 Jun; 9(11):e015594. PubMed ID: 32427023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.